Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • Country/Region
    • Clinic Portal
      • +0034963905310
    • Request Information
    • +34 96 390 53 10
    • Part of brands: |
    InternationalInternational
    • Country/Region
      • Part of brands: |
      • We guide you
        • Fertility
          • What to do if…
        • Prevent Inherited Diseases
          • Carrier Genetic Test
        • Worry-free Pregnancy
          • NACE
          • Prenatal Diagnostics
          • Newborn Health
      • Reproductive Health
        • Specialists
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • POC
          • SAT
          • Newborn Screening
        • Patients
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • SAT
          • POC
      • Diagnostics
      • About us
        • Igenomix Research
        • About Igenomix
        • Igenomix Worldwide
      • Academy
      • Blog
      Genomics Precision Diagnostic > Neurology Precision Panel > Congenital Muscular Dystrophies and Myopathies Precision Panel

      Congenital Muscular Dystrophies and Myopathies Precision Panel

      Congenital Muscular Dystrophies are an inherited group of progressive myopathic disorders resulting from defects in a number of genes responsible for normal muscle function, resulting in progressive muscle weakness without a central or peripheral nerve abnormality.
      Overview
      Indication
      Clinical Utility
      Genes & Diseases
      Methodology
      References

      Overview

      • Congenital Muscular Dystrophies are an inherited group of progressive myopathic disorders resulting from defects in a number of genes responsible for normal muscle function, resulting in progressive muscle weakness without a central or peripheral nerve abnormality. The genes responsible for these diseases are specific muscle proteins that allow for proper contraction and relaxation of the muscles. Muscular dystrophies are classified according to the clinical phenotype, pathology and mode of inheritance. Inheritance pattern includes X-lined, autosomal recessive and autosomal dominant. Some examples include: 

        • X-linked: Duchenne, Becker, Emery-Dreifuss 
        • Autosomal dominant: Facioscapulohumeral, distal, ocular, oculopharyngeal 
        • Autosomgal recessive: Limb-girdle form 

         

      • Congenital Myopathies are a group of genetic diseases that predominantly affect the muscles. The typical features can be found in neonates and infants, children or even adults. The classification of congenital myopathies follows a genetic criterion. However, the genotype-phenotype correlation remains variable and overlapping with congenital muscular dystrophies. Some examples of congenital myopathies include Nemaline Myopathy, Central Core Disease and Multiminicore Disease amongst others. Both congenital myopathies and muscular dystrophies carry a high risk of developing restrictive lung disease and orthopedic deformities.  

      • The Igenomix Congenital Muscular Dystrophies and Myopathies Precision Panel can be used as a tool for an accurate diagnosis and differential diagnosis of muscle weakness ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved, and their high or intermediate penetrance. 

      Indication

      • The Igenomix Congenital Muscular Dystrophies and Myopathies Precision Panel is used for patients with a clinical suspicion or diagnosis with or without the following symptoms: 
        • Early-onset muscle weakness 
        • Decreased muscle tone 
        • Hypoactive deep tendon reflexes 
        • Delayed motor milestones 
        • Muscle atrophy 
        • Abnormally fixed joints 
        • Muscle deformities and contractures 
        • Family history of congenital myopathy or muscle dystrophy 

      Clinical Utility

      The clinical utility of this panel is: 

      • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient.   
      • Early initiation of treatment involving a multidisciplinary team focusing on intensive physiotherapy and rehabilitation, bracing and surgical interventions and medical care to prevent complications and improve symptoms. 
      • Risk assessment of asymptomatic family members according to the mode of inheritance via genetic counselling.
      • Improvement of delineation of genotype-phenotype correlation given the variability of severity and course of disease.  

      Genes & Diseases

      Methodology

      References

      See scientific referrals

      Cassandrini, D., Trovato, R., Rubegni, A., Lenzi, S., Fiorillo, C., & Baldacci, J. et al. (2017). Congenital myopathies: clinical phenotypes and new diagnostic tools. Italian Journal Of Pediatrics, 43(1). doi: 10.1186/s13052-017-0419-z 

      Colombo, I., Scoto, M., Manzur, A., Robb, S., Maggi, L., & Gowda, V. et al. (2014). Congenital myopathies: Natural history of a large pediatric cohort. Neurology, 84(1), 28-35. doi: 10.1212/wnl.0000000000001110 

      Millichap, J. (2010). Congenital Muscular Dystrophies and Cognitive Impairment. Pediatric Neurology Briefs, 24(11), 87. doi: 10.15844/pedneurbriefs-24-11-8  

      Butterfield R. J. (2019). Congenital Muscular Dystrophy and Congenital Myopathy. Continuum (Minneapolis, Minn.), 25(6), 1640–1661. https://doi.org/10.1212/CON.0000000000000792 

      Sundaram, C., Uppin, M., & Meena, A. (2013). Spectrum of congenital myopathies: A single centre experience. Neurology India, 61(3), 254. doi: 10.4103/0028-3886.115064 

      Falsaperla, R., Praticò, A. D., Ruggieri, M., Parano, E., Rizzo, R., Corsello, G., Vitaliti, G., & Pavone, P. (2016). Congenital muscular dystrophy: from muscle to brain. Italian journal of pediatrics, 42(1), 78. https://doi.org/10.1186/s13052-016-0289-9 

      Gilbreath, H. R., Castro, D., & Iannaccone, S. T. (2014). Congenital myopathies and muscular dystrophies. Neurologic clinics, 32(3), 689–viii. https://doi.org/10.1016/j.ncl.2014.04.006 

      descargar

      Detail description

      Download

      Request Information


      WE GUIDE YOU

      Fertility
      Inherited diseases prevention
      Healthy pregnancy

      To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

      OUR SERVICES

      Genetic solutions
      For patients
      How to send a sample?
      User manual

      ABOUT US

      About Igenomix
      Contact
      Quality
      Complaints
      Work with us

      FOLLOW IGENOMIX

        + 96 390 53 10
        Write us
      • Argentina
      • Brazil
      • Canada
      • Chile
      • Colombia
      • Europe
      • France
      • Germany
      • India
      • Italy
      • Japan
      • Korea
      • Mexico
      • Perú
      • Russia
      • Spain
      • Taiwan
      • The Middle East
      • Turkey
      • United Kingdom
      • United States
      • Vietnam
      Country/Region

      [2021] © Igenomix Privacy policy Quality policy Legal note Cookies policyNews and Press

      Request Information

















      • We guide you
        • Fertility
          • What to do if…
        • Prevent Inherited Diseases
          • Carrier Genetic Test
        • Worry-free Pregnancy
          • NACE
          • Prenatal Diagnostics
          • Newborn Health
      • Reproductive Health
        • Specialists
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • POC
          • SAT
          • Newborn Screening
        • Patients
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • SAT
          • POC
      • Diagnostics
      • About us
        • Igenomix Research
        • About Igenomix
        • Igenomix Worldwide
      • Academy
      • Blog
      • Country/Region
      • +34 96 390 53 10
      • Clinic Portal
      • Request Information

      We are using cookies to give you the best experience on our website.

      You can find out more about which cookies we are using or switch them off in settings.

      International
      Powered by  GDPR Cookie Compliance
      Privacy Overview

      This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

      Strictly Necessary Cookies

      Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

      If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

      3rd Party Cookies

      This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

      Keeping this cookie enabled helps us to improve our website.

      Please enable Strictly Necessary Cookies first so that we can save your preferences!

      Cookie Policy

      More information about our Cookie Policy